-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Reiterates Overweight on OrthoPediatrics, Raises Price Target to $25

Benzinga·08/05/2026 15:58:23
Listen to the news
Piper Sandler analyst Matt O'Brien reiterates OrthoPediatrics (NASDAQ:KIDS) with a Overweight and raises the price target from $22 to $25.